• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ensuring adequate payment for the use of new technology.

作者信息

Kaden R J

出版信息

Healthc Financ Manage. 1998 Feb;52(2):46-52.

PMID:10176449
Abstract

To ensure that proper reimbursement is obtained for utilization of a new technology, providers should demonstrate to payers the long-term cost-effectiveness of the new technology. Providers need to determine the incremental costs incurred in using the technology and various payers' payment rates for such use. If preliminary analysis shows that reimbursement for the technology may be insufficient, providers then should conduct a detailed analysis of the new technology. This analysis should assemble comparative data of internal and external performance benchmarks from various sources, including state, regional, and national databases. In addition, providers should assess the long-term savings achieved by using the new technology, such as reductions in hospital readmissions and repeated procedures. Managed care payers are likely to find such data persuasive in determining whether to increase payment rates for a new device or therapy.

摘要

相似文献

1
Ensuring adequate payment for the use of new technology.
Healthc Financ Manage. 1998 Feb;52(2):46-52.
2
Negotiating payment for new technology purchases.协商新技术采购的付款事宜。
Healthc Financ Manage. 2002 Dec;56(12):44-8.
3
From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.从医学发明到临床实践:新设备程序与技术面临的报销挑战——第3部分:支付
J Am Coll Radiol. 2006 Nov;3(11):842-50. doi: 10.1016/j.jacr.2006.02.027.
4
Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.引入一种有效的新疗法后,经济上的赢家和输家取决于支付系统的类型。
Am J Manag Care. 1997 May;3(5):743-9.
5
Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.药物洗脱支架在现实应用中9个月随访的成本效益:西西里药物洗脱支架注册研究结果
J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):322-9. doi: 10.2459/JCM.0b013e3283276ebb.
6
A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.新兴医疗技术研究与应用中的范式转变:基于证据生成的覆盖范围
J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008.
7
One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.药物洗脱支架植入治疗多支冠状动脉疾病的一年临床结果及总成本
J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601. doi: 10.2459/JCM.0b013e32801051f4.
8
The impact of reimbursement changes for intracoronary stents on providers and Medicare.冠状动脉支架报销政策变化对医疗服务提供者和医疗保险的影响。
Am J Manag Care. 1998 Aug;4(8):1097-102.
9
Changing views about "usual charges".
Healthc Financ Manage. 2004 Jan;58(1):32-6.
10
Of orphans and balloons.关于孤儿和气球。
Physician Exec. 1991 Sep-Oct;17(5):41-3.